| Date Filed | Type | Description |
| 10/10/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 11.1% stake in Zentalis Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Vital Farms, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Sutro Biopharma, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Essa Pharma Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Zymeworks Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.4% stake in VectivBio Holding AG |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 2.2% stake in Prometheus Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.1% stake in Freeline Therapeutics Holdings plc |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 3.7% stake in Cogent Biosciences, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.6% stake in Annexon, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.5% stake in Praxis Precision Medicines, Inc. |
| 02/14/2023 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in KnowBe4, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.6% stake in Mirum Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.6% stake in Marinus Pharmaceuticals, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.3% stake in Aura Biosciences, Inc. |
| 02/14/2023 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7% stake in 908 Devices Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.6% stake in Collegium Pharmaceutical, Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.3% stake in Vital Farms, Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 5.9% stake in Sutro Biopharma, Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 8.5% stake in Praxis Precision Medicines, Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0.6% stake in KalVista Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 0% stake in Kala Pharmaceuticals, Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.7% stake in Freeline Therapeutics Holdings plc |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.5% stake in ESSA Pharma Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 1.2% stake in Entasis Therapeutics Holdings, Inc. |
| 02/14/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.1% stake in Zymeworks Inc. |
| 02/14/2022 |
SC 13G/A
| EVENTIDE ASSET MANAGEMENT, LLC reports a 7.4% stake in Annexon, Inc. |
| 02/14/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 6.7% stake in VectivBio Holding AG |
| 02/14/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 9.6% stake in Prometheus Biosciences, Inc. |
| 02/14/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 8.8% stake in Cogent Biosciences, Inc. |
| 02/10/2022 |
SC 13G
| EVENTIDE ASSET MANAGEMENT, LLC reports a 10.1% stake in KnowBe4, Inc. |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 02/12/2021 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
|